text
"['\n2. 주요 제품 및 서비스\n가. 주요제품 매출\n(단위 : 백만원, %)\n사업부문\n매출유형\n품 \xa0 목\n구체적용도\n주요상표등\n제10기\n제9기\n제8기\n매출액\n비율\n매출액\n비율\n매출액\n비율\n의약품 등\n제품\n그로트로핀\n성장호르몬\n-\n61,505\n9.68\n44,297\n\xa0 \xa0 7.47\xa0\n32,452\n\xa0 5.53\xa0\n모티리톤\n기능성소화불량제\n-\n34,115\n5.37\n31,211\n\xa0 5.26\xa0\n29,026\n\xa0 4.95\xa0\n슈가논\n당뇨병치료제\n-\n23,968\n3.77\n30,438\n\xa0 \xa05.13\xa0\n23,757\n4.05\xa0\n가스터\n소화성궤양치료제\n-\n23,438\n3.69\n23,693\n\xa0 \xa04.00\xa0\n22,320\n\xa0 3.80\xa0\n주블리아\n손발톱무좀치료제\n-\n27,928\n4.40\n27,306\n\xa0 \xa04.60\xa0\n22,267\n\xa03.80\xa0\n오팔몬\n허혈성개선제\n-\n24,628\n3.88\n23,377\n\xa0 3.94\xa0\n23,178\n\xa03.95\xa0\n플라비톨\n항혈전제\n-\n22,226\n3.50\n21,786\n\xa0 3.67\xa0\n18,785\n\xa03.20\xa0\n스티렌\n위점막보호제\n-\n20,404\n3.21\n19,535\n\xa0 3.29\xa0\n20,869\n\xa03.56\xa0\n리피논\n고지혈증치료제\n-\n16,209\n2.55\n17,087\n\xa0 \xa02.88\xa0\n14,343\n\xa02.44\xa0\n바라클\nB형간염치료제\n-\n7,559\n1.19\n7,316\n\xa0 \xa01.23\xa0\n6,961\n\xa01.19\xa0\n상품\n캔박카스\n에너지드링크\n-\n93,922\n14.78\n80,763\n\xa013.61\xa0\n82,146\n\xa014.00\xa0\n이달비\n고혈압치료제\n-\n11,217\n1.77\n10,351\n\xa0 1.74\xa0\n9,550\n\xa01.63\xa0\n기타\n-\n-\n-\n268,273\n42.22\n256,068\n\xa043.18\xa0\n281,074\n47.90\xa0\n합계\n-\n-\n-\n-\n635,393\n100.00\n593,228\n\xa0100.00\xa0\n586,728\n100.00\xa0\n나. 주요제품 가격변동추이\n(단위 : 원)\n구 \xa0분\n제10기\n제9기\n제8기\n전문의약품\n스티렌(1Tab)\n112\n112\n112\n리피논(20㎎. 1Tab)\n677\n677\n682\n플라비톨(1Tab)\n1,149\n1,149\n1,153\n모티리톤(1Tab)\n152\n152\n152\n슈가논(1Tab)\n737\n737\n737\n(1) 산출기준- 전문의약품 : 보험약가 기준(2) 주요 가격변동 원인- 전문의약품 : 선별등재시스템(PLS), 특허만료의약품 약가인하, 일괄약가인하, 사용량 약가연동제 등 정부의 약가인하 정책에 따른 가격통제를 받음\n']"
